These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17146078)

  • 1. Hyperlactatemia due to nevirapine.
    Panos G; Kopterides P; Falagas ME
    Ann Intern Med; 2006 Dec; 145(11):867-8. PubMed ID: 17146078
    [No Abstract]   [Full Text] [Related]  

  • 2. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
    Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
    Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine-associated Stevens-Johnson syndrome.
    Warren KJ; Boxwell DE; Kim NY; Drolet BA
    Lancet; 1998 Feb; 351(9102):567. PubMed ID: 9492778
    [No Abstract]   [Full Text] [Related]  

  • 4. [Toxic epidermal necrolysis in relation with nevirapine].
    Vera Méndez FJ; Martínez Madrid OJ; García Henarejos JA; García Solano J; Vilaplana García R
    An Med Interna; 2000 Aug; 17(8):448-9. PubMed ID: 11218998
    [No Abstract]   [Full Text] [Related]  

  • 5. Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors?
    Morlese JF; Qazi NA; Gazzard BG; Nelson MR
    AIDS; 2002 Sep; 16(13):1840-1. PubMed ID: 12218402
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis and nevirapine].
    Palacios R; Santos J; González M; Márquez M
    Med Clin (Barc); 2000 Apr; 114(15):597-8. PubMed ID: 10846681
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of hyperlactatemia: no need for routine lactate measurements.
    Brinkman K
    AIDS; 2001 Apr; 15(6):795-7. PubMed ID: 11371695
    [No Abstract]   [Full Text] [Related]  

  • 8. [Stevens-Johnson syndrome due to nevirapine].
    García Fernández D; García-Patos Briones V; Mollet Sánchez J; Castells Rodellas A
    Rev Clin Esp; 2000 Mar; 200(3):179-80. PubMed ID: 10804771
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe hepatic failure related to nevirapine treatment.
    Cattelan AM; Erne E; Salatino A; Trevenzoli M; Carretta G; Meneghetti F; Cadrobbi P
    Clin Infect Dis; 1999 Aug; 29(2):455-6. PubMed ID: 10476768
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion.
    Antoniou T; Weisdorf T; Gough K
    CMAJ; 2003 Jan; 168(2):195-8. PubMed ID: 12538549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
    Koh MT
    Int J Infect Dis; 2007 Jan; 11(1):85-6. PubMed ID: 16581278
    [No Abstract]   [Full Text] [Related]  

  • 12. Nevirapine-induced Stevens-Johnson syndrome in a mother and son.
    Liechty CA; Solberg P; Mwima G; Were W; Weidle PJ; Mermin J
    AIDS; 2005 Jun; 19(9):993-4. PubMed ID: 15905686
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen.
    Johnson S; Chan J; Bennett CL
    Ann Intern Med; 2002 Jul; 137(2):146-7. PubMed ID: 12118982
    [No Abstract]   [Full Text] [Related]  

  • 14. Nevirapine-induced hepatitis treated with corticosteroids?
    Leitze Z; Nadeem A; Choudhary A; Saul Z; Roberts I; Manthous CA
    AIDS; 1998 Jun; 12(9):1115-7. PubMed ID: 9662216
    [No Abstract]   [Full Text] [Related]  

  • 15. Spanish study looks at the effect of nevirapine on the liver.
    TreatmentUpdate; 2001 Jul; 13(3):4-5. PubMed ID: 11569988
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV drug nevirapine (Viramune): risk of severe hepatotoxicity.
    Wooltorton E
    CMAJ; 2004 Mar; 170(7):1091. PubMed ID: 15051689
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA-Cw8 primarily associated with hypersensitivity to nevirapine.
    Gatanaga H; Yazaki H; Tanuma J; Honda M; Genka I; Teruya K; Tachikawa N; Kikuchi Y; Oka S
    AIDS; 2007 Jan; 21(2):264-5. PubMed ID: 17197830
    [No Abstract]   [Full Text] [Related]  

  • 18. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy.
    Bourezane Y; Salard D; Hoen B; Vandel S; Drobacheff C; Laurent R
    Clin Infect Dis; 1998 Nov; 27(5):1321-2. PubMed ID: 9827291
    [No Abstract]   [Full Text] [Related]  

  • 19. Nevirapine-induced resistance is a problem.
    S Afr Med J; 2004 May; 94(5):338. PubMed ID: 15211947
    [No Abstract]   [Full Text] [Related]  

  • 20. Nevirapine-related adverse events in a patient receiving a fixed-drug combination pill.
    Daniel OJ; Krain AB; Ogun SA; Odusoga OL; Boyle BA
    J Natl Med Assoc; 2005 Dec; 97(12):1719-21. PubMed ID: 16396066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.